Researchers from the United States of America have developed a promising new vaccine that targets phosphorylated tau, a key protein responsible for the toxic "tangles" that drive Alzheimer’s disease. Published in Alzheimer’s & Dementia, the study shows that by using harmless virus-like particles to "train" the immune system, the vaccine successfully triggers a strong antibody response against these brain-damaging proteins.
In tests on both mice and rhesus macaques, the vaccine proved to be safe and highly effective. Vaccinated subjects showed a significant reduction in tau buildup and brain shrinkage, which translated to better preservation of memory and motor functions. This cross-species success is a major milestone, suggesting the vaccine's design is robust enough for primate immune systems.
The most exciting takeaway is the vaccine's potential for human use. Because the antibodies it produces were able to identify and bind to tau in human Alzheimer’s brain samples, researchers are optimistic about moving into clinical trials. This "anti-tangle" shot could eventually offer a proactive way to reduce disease severity and protect long-term cognitive health.
Read more via the link